相关实验视频
Updated: Jan 12, 2026

06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
11.1K
2型糖尿病的药理疗法:未来的方法
1Health and Life Sciences, Aston University, Birmingham, UK. c.j.bailey@aston.ac.uk.
Diabetologia
|November 1, 2025
概括
新的非胰岛素疗法正在出现,以改善2型糖尿病的管理. 有前途的药物向因克列通路和激动剂,以更好地控制血糖和体重调节,为改善患者的治疗结果提供希望.
科学领域:
- 内分泌学和新陈代谢学
- 药理学 药理学是指药理学的学科.
- 糖尿病研究 糖尿病研究
背景情况:
- 2型糖尿病的管理仍然具有挑战性,许多患者未能实现最佳的血糖控制,尽管存在治疗方法.
- 慢性高血糖导致严重的长期并发症.
研究的目的:
- 审查新兴的非胰岛素药物和2型糖尿病的治疗方法.
- 为了确定未来的治疗方法,增强降血糖,提高安全性,并管理并发性疾病.
主要方法:
- 关于2型糖尿病早期治疗发展的叙述性综述.
- 分析新的机制和目标,包括基于的,抗体,小分子和新兴技术.
主要成果:
- 同激素和多激素的基于英克雷丁和基于氨酸的可以改善血糖控制和体重.
- 这些药物可以增强胰岛素分泌,保存β细胞,改善葡萄糖代谢,减少葡萄糖和减轻脂肪肝疾病.
- 其他正在开发的疗法针对线粒体功能,营养代谢和食欲调节.
结论:
- 未来的非胰岛素疗法,特别是基于的激动剂,具有改变2型糖尿病管理的巨大潜力.
- 克服针对性交付和非目标效应的挑战对于临床翻译至关重要.
- 基于烯的药物最近取得的成功为制药管道带来了乐观的情绪.
相关概念视频
Diabetes: Management and Pharmacotherapy
856
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
856
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Glucagon-like Receptor Agonists
832
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
832
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Oral Hypoglycemic Agents: Biguanides and Glitazones
571
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
571
Carbohydrate Metabolism
13.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.8K

